AU519567B2 - Psychopharmacological penta and hexa-peptides - Google Patents

Psychopharmacological penta and hexa-peptides

Info

Publication number
AU519567B2
AU519567B2 AU37780/78A AU3778078A AU519567B2 AU 519567 B2 AU519567 B2 AU 519567B2 AU 37780/78 A AU37780/78 A AU 37780/78A AU 3778078 A AU3778078 A AU 3778078A AU 519567 B2 AU519567 B2 AU 519567B2
Authority
AU
Australia
Prior art keywords
psychopharmacological
hexa
penta
peptides
psychopharmacological penta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37780/78A
Other languages
English (en)
Other versions
AU3778078A (en
Inventor
H. M Greven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of AU3778078A publication Critical patent/AU3778078A/en
Application granted granted Critical
Publication of AU519567B2 publication Critical patent/AU519567B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU37780/78A 1977-07-13 1977-07-05 Psychopharmacological penta and hexa-peptides Expired AU519567B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NLNL7707781 1977-07-13
NL7707781A NL7707781A (nl) 1977-07-13 1977-07-13 Psychofarmacologische peptiden.

Publications (2)

Publication Number Publication Date
AU3778078A AU3778078A (en) 1980-01-10
AU519567B2 true AU519567B2 (en) 1981-12-10

Family

ID=19828866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37780/78A Expired AU519567B2 (en) 1977-07-13 1977-07-05 Psychopharmacological penta and hexa-peptides

Country Status (16)

Country Link
US (1) US4203975A (US08088816-20120103-C00036.png)
JP (1) JPS5419934A (US08088816-20120103-C00036.png)
AU (1) AU519567B2 (US08088816-20120103-C00036.png)
BE (1) BE868953A (US08088816-20120103-C00036.png)
CA (1) CA1108123A (US08088816-20120103-C00036.png)
DE (1) DE2830489A1 (US08088816-20120103-C00036.png)
DK (1) DK149454C (US08088816-20120103-C00036.png)
ES (1) ES471672A1 (US08088816-20120103-C00036.png)
FI (1) FI67367C (US08088816-20120103-C00036.png)
FR (1) FR2397395A1 (US08088816-20120103-C00036.png)
GB (1) GB2001076B (US08088816-20120103-C00036.png)
IE (1) IE47547B1 (US08088816-20120103-C00036.png)
LU (1) LU79960A1 (US08088816-20120103-C00036.png)
NL (1) NL7707781A (US08088816-20120103-C00036.png)
SE (1) SE443789B (US08088816-20120103-C00036.png)
ZA (1) ZA783713B (US08088816-20120103-C00036.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530062B2 (en) * 1979-02-21 1983-06-30 Akzo N.V. Psycho-pharmacological peptides
JPH0195597U (US08088816-20120103-C00036.png) * 1987-12-17 1989-06-23
EP3000836B1 (en) * 2013-05-22 2018-12-26 National Institute of Advanced Industrial Science and Technology Photodegradable crosslinking agent
NZ714555A (en) * 2013-09-17 2020-03-27 Obi Pharma Inc Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
AU2017252128B2 (en) 2016-04-22 2024-06-06 Obi Pharma, Inc. Cancer immunotherapy by immune activation or immune modulation via Globo series antigens
JP2019527690A (ja) 2016-07-27 2019-10-03 オービーアイ ファーマ,インコーポレイテッド 免疫原性/治療用グリカン組成物およびその使用
EP3491026A4 (en) 2016-07-29 2020-07-29 OBI Pharma, Inc. HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803119A (en) * 1970-04-20 1974-04-09 Daiichi Seiyaku Co Pantetheine-s-sulfonic acid derivatives and salts thereof
NL175293C (nl) * 1972-02-08 1984-10-16 Akzo Nv Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met psychofarmacologische werking, alsmede werkwijze voor het bereiden van een van vasopressine afgeleid peptide.

Also Published As

Publication number Publication date
CA1108123A (en) 1981-09-01
IE781291L (en) 1979-01-13
JPS6220200B2 (US08088816-20120103-C00036.png) 1987-05-06
DE2830489A1 (de) 1979-01-25
ES471672A1 (es) 1979-09-16
BE868953A (fr) 1979-01-12
DK314978A (da) 1979-01-14
ZA783713B (en) 1979-07-25
SE7807759L (sv) 1979-01-14
FI782195A (fi) 1979-01-14
IE47547B1 (en) 1984-04-18
FR2397395B1 (US08088816-20120103-C00036.png) 1981-01-16
DK149454B (da) 1986-06-16
JPS5419934A (en) 1979-02-15
SE443789B (sv) 1986-03-10
AU3778078A (en) 1980-01-10
GB2001076B (en) 1982-01-27
FR2397395A1 (fr) 1979-02-09
DK149454C (da) 1986-11-17
GB2001076A (en) 1979-01-24
FI67367C (fi) 1985-03-11
FI67367B (fi) 1984-11-30
LU79960A1 (fr) 1979-04-09
NL7707781A (nl) 1979-01-16
US4203975A (en) 1980-05-20

Similar Documents

Publication Publication Date Title
AU520095B2 (en) Phenoxybenzyloxycarbonyl derivatives and process
AU518876B2 (en) Benzyl i dene-camphors
AU521993B2 (en) Rack
AU516291B2 (en) Traizoles and imidazoles
AU4214978A (en) Amplifier
AU3216478A (en) Phenylcarbamoyl-2-pyrazolines
AU3216278A (en) Phenylcarbamoyl-pyrazolines
AU519567B2 (en) Psychopharmacological penta and hexa-peptides
AU536015B2 (en) Rack
AU523766B2 (en) Sail support
AU522055B2 (en) 1-arylalkylimidazoles
AU3239278A (en) Dithienylalkylamines
AU516655B2 (en) Activating chalcopyrite-pyrite concentrated
AU3307178A (en) Chloroacetanylides
AU517028B2 (en) Imidazoles
AU521753B2 (en) Racks
AU3706678A (en) Pyridazinylhydrazines
AU524644B2 (en) Heat-recoverable connector
AU3246878A (en) Arylenedioxy-bis-diketones
SU637698A1 (ru) Экстензометр
AU4859679A (en) Stand structure
AU4188478A (en) 2-heterocyclyalkyl-6-methoxy-naphthalene
AU3234978A (en) Carbimidocarbonylphenylformamidines
SU677799A1 (ru) Способ деформировани заготовок
SU674188A2 (ru) Способ синхронизации генераторов